Evidence map›Paper›PMID 36101544›Full record

ArticleBMJ neurology open2022

Posterior reversible encephalopathy syndrome presenting with thrombotic microangiopathy triggered by malignant hypertension: a case report and literature review.

Hitomi Onomura, Takahiro Shimizu, Junichiro Suzuki, Noriyoshi Nakai, Yuri Teramachi, Kato Tomonori, Ichiro Akiguchi, Yasuhiro Ito

Open access · diamondAbstract read
In one paragraph

Article in BMJ neurology open, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 43% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 2 citations in OpenAlex.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Hitomi OnomuraDepartment of Neurology, Toyota Memorial Hospital, Toyota, Aichi, Japan.
Takahiro ShimizuDepartment of Neurology, Toyota Memorial Hospital, Toyota, Aichi, Japan.
Junichiro SuzukiDepartment of Neurology, Toyota Memorial Hospital, Toyota, Aichi, Japan.
Noriyoshi NakaiDepartment of Neurology, Toyota Memorial Hospital, Toyota, Aichi, Japan.
Yuri TeramachiDepartment of Nephrology, Toyota Memorial Hospital, Toyota, Aichi, Japan.
Kato TomonoriDepartment of Hematology, Toyota Memorial Hospital, Toyota, Aichi, Japan.
Ichiro AkiguchiCenter of Neurological and Cerebrovascular Diseases, Takeda Hospital, Kyoto, Japan.
Yasuhiro ItoDepartment of Neurology, Toyota Memorial Hospital, Toyota, Aichi, Japan.
Toyota Memorial Hospital · JPTakeda (Japan) · JP

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Posterior reversible encephalopathy syndrome (PRES) is a disease characterised by reversible subcortical vasogenic oedema, neurological symptoms and abnormal findings on head imaging. It is recognised as one of the most prominent organ disorders in hypertensive emergencies but is rarely associated with thrombotic microangiopathy (TMA). Case presentation: A woman in her 40s with untreated hypertension had occasional headaches in the past 4 months. The headaches worsened during the 3 weeks prior to admission. On the day of admission, the patient presented with severe headache accompanied by frequent vomiting. MRI of the head revealed oedematous changes in the brainstem, including the subcortical, cerebellum and pons. Fundus examination revealed hypertensive retinopathy with papilloedema. Blood tests indicated thrombocytopenia, renal dysfunction and haemolytic anaemia, and a blood smear confirmed fragmented erythrocytes. Coombs' test, and tests for ADAMTS13 activity and infectious and autoimmune diseases were negative. The patient was diagnosed with PRES, secondary to malignant hypertension (MH) and associated with TMA. Antihypertensive therapy promptly improved the clinical symptoms, blood pressure, and the abnormal MRI and blood test findings. The patient was discharged from the hospital 20 days after admission. Conclusions: We report a rare case of PRES that was associated with TMA and triggered by MH. Antihypertensive therapy was effective in alleviating the associated adverse clinical symptoms. Differentiation of underlying diseases is essential for early intervention, since treatment depends on factors causing TMA.

Indexed as

cerebral blood flowhaematologyheadachehypertensive encephathrombophilia

Identifiers

PMID36101544
PMCPMC9413191
OpenAlexW4292939143

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.